The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

RAS mutation may be even more important than determining treatment options, according to MDAnderson

coloCan
coloCan CSN Member Posts: 1,944 Member
edited July 2014 in Colorectal Cancer #1

www.mdanderson.org/publications/oncolog/ras-mutation-status-may-predict-outcomes-after-surgery-for-colorectal-cancer-liver-metastases-oncol

Direct link doesn't seem to work,but if you type in "ras mutation" in search box of page that appears, you'll get this interesting article,if so interested (key word:"MAY")

(something calledCH4987655 (Ro4987655) is a MEK inhibitor that may prove useful with Ras/Raf mutations,tho in early phase trial 

Also,MGD007 is starting to enroll people for trial......and its not named for James Bonds' unknown cousin)

 

 

Like Care

Comments

  • coloCan
    coloCan CSN Member Posts: 1,944 Member
    #2
    For those of you in Europe:

    a company named Xbiotech is starting to enroll people in a phase III study of something called "Xilonix"....FYI

    (again,FDA may be fast-tracking MGD007)

     

    Like Care
  • coloCan
    coloCan CSN Member Posts: 1,944 Member
    #3
    coloCan said:

    For those of you in Europe:

    a company named Xbiotech is starting to enroll people in a phase III study of something called "Xilonix"....FYI

    (again,FDA may be fast-tracking MGD007)

     

    another antibody making its way thru trials is

    Sym004...................

    and here's something someone may find of interest onKRAS/NRAS mutations(interesting site too)

    www.mycancergenome.org/content/disease/colorectal-cancer/nras/316

    PS:Just came across this,a combo of cetuximab and trastuzumab

    http://onlinelibrary.wiley.com/doi/10.1111/cpr.12125/abstract

     

     

    Like Care
  • Quick2Listen
    Quick2Listen CSN Member Posts: 1
    #4
    Kras mutation

    Although there are many genetic mutations classified as Kras + Tumors with mutated KRAS genes do not respond to treatment with cetuximab or panitumumab as yet

     

    Like Care
  • coloCan
    coloCan CSN Member Posts: 1,944 Member
    #5
    Quick2Listen said:

    Kras mutation

    Although there are many genetic mutations classified as Kras + Tumors with mutated KRAS genes do not respond to treatment with cetuximab or panitumumab as yet

     

    Update on one potential,plus more on another:

    Supposedly good results thus far for Xilonix

    www.sys-con.com/node/3168361

    and phaae III starting for MGN 1703 (tho i think in Germany now)

    also,good news from phase iii on Ramucirumab........

    Like Care

Discussion Boards